Prelude Therapeutics Balance Sheet (2019-2026) | PRLD

Balance Sheet Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
343.12M61.42M35.87M55.68M54.75M56.07M34.65M22.25M30.49M19.94M29.34M28.75M31.87M15.18M16.52M44.31M77.30M50.77M35.26M84.80M
Short-term Investments (Quarter)
259.44M259.40M214.56M195.60M172.02M171.12M154.05M228.54M214.61M207.64M177.22M152.02M142.49M121.14M58.80M47.46M7.42M67.96M59.80M
Cash & Current Investments (Quarter)
343.12M320.87M295.28M270.23M250.35M228.09M205.77M176.30M259.03M234.55M236.98M205.97M183.89M157.67M137.66M103.12M124.76M58.19M103.21M144.60M
Prepaid Assets (Quarter)
1.46M5.03M3.88M3.78M2.32M2.85M2.65M3.01M5.22M4.41M2.65M3.44M2.87M2.76M2.28M3.33M3.66M3.37M2.48M3.04M
Current Assets (Quarter)
344.57M325.90M295.12M269.97M248.62M226.89M204.38M175.26M260.21M234.92M235.59M205.37M182.71M156.39M135.90M102.40M76.88M58.33M105.69M84.59M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
3.11M3.21M3.93M4.12M4.29M5.11M4.91M5.37M6.08M6.62M7.33M7.29M7.55M7.20M6.77M6.39M5.96M5.53M5.11M4.72M
Other Non-Current Assets (Quarter)
4.04M4.04M4.04M4.04M4.04M12.28M4.04M12.47M4.04M0.29M4.04M4.04M0.11M4.04M4.04M3.23M0.11M3.23M
Non-Current Assets (Quarter)
5.01M5.32M9.98M10.70M10.43M15.43M16.12M23.06M20.40M23.59M42.08M41.74M41.58M40.83M39.62M38.86M38.04M36.42M35.62M35.05M
Assets (Quarter)
349.58M331.22M305.10M280.67M259.06M242.33M220.50M198.32M280.61M258.51M277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
6.84M11.06M7.84M7.39M6.27M10.25M6.78M7.08M5.58M5.17M4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M
Payables (Quarter)
6.84M11.06M7.84M7.39M6.27M10.25M6.78M7.08M5.58M5.17M4.58M5.31M6.17M5.92M7.73M5.83M4.96M2.53M3.98M2.07M
Accumulated Expenses (Quarter)
2.33M6.76M9.62M3.02M7.72M9.92M13.09M3.11M5.04M11.25M15.77M10.15M11.43M13.58M15.21M11.30M5.88M6.49M12.53M2.53M
Other Accumulated Expenses (Quarter)
0.03M0.57M0.09M0.35M0.29M0.17M0.52M0.89M0.81M0.82M0.94M0.80M0.46M0.80M0.77M0.70M0.86M0.96M0.96M0.91M
Current Leases (Quarter)
1.40M1.84M1.74M1.86M1.82M1.39M1.83M1.39M0.94M0.47M1.48M2.19M2.23M2.37M2.49M2.60M2.71M2.73M2.74M2.76M
Current Deferred Revenue (Quarter)
3.00M33.73M30.95M
Total Current Liabilities (Quarter)
14.68M19.66M19.20M16.07M15.81M21.56M21.70M19.66M15.19M16.89M21.83M17.64M23.34M22.22M25.64M19.79M20.91M18.19M52.99M41.72M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
1.80M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.54M0.31M0.39M15.41M15.45M15.46M18.14M15.32M15.27M15.21M15.13M15.04M14.96M
Other Non-Current Liabilities (Quarter)
2.40M2.40M3.36M3.36M3.36M3.36M3.36M3.34M3.28M3.21M3.15M3.09M3.03M2.97M2.90M2.84M2.78M
Total Non-Current Liabilities (Quarter)
19.20M16.46M15.81M21.56M21.70M19.66M15.19M16.89M37.24M33.09M38.80M37.64M40.97M35.05M36.11M33.32M69.84M56.68M
Total Liabilities (Quarter)
15.22M19.98M19.20M18.86M18.21M24.92M25.06M23.02M18.55M20.25M40.58M36.37M42.02M40.79M44.06M38.08M39.08M36.22M72.68M59.46M
Shareholder's Equity
Common Equity (Quarter)
334.36M311.24M285.90M261.81M240.84M217.41M195.44M175.30M262.06M238.26M237.09M210.73M182.28M156.43M131.46M103.18M75.84M58.53M68.64M60.18M
Shareholder's Equity (Quarter)
334.36M311.24M285.90M261.81M240.84M217.41M195.44M175.30M262.06M238.26M237.09M210.73M182.28M156.43M131.46M103.18M75.84M58.53M68.64M60.18M
Liabilities and Shareholders Equity (Quarter)
349.58M331.22M305.10M280.67M259.06M242.33M220.50M198.32M280.61M258.51M277.67M247.11M224.29M197.22M175.51M141.26M114.92M94.75M141.31M119.64M
Retained Earnings (Quarter)
-155.60M-0.18M-0.71M-2.31M-2.29M-305.90M-334.56M-362.28M-392.70M-0.60M-456.39M-487.82M-0.29M-554.80M0.04M-615.60M-646.90M0.00M-683.06M-693.40M
Treasury Shares (Quarter)
0.84M0.72M0.61M0.51M0.17M0.17M0.17M0.16M0.12M0.11M0.10M0.09M0.08M0.07M0.06M0.38M0.34M0.29M0.22M0.44M